Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Dexamethasone for Prevention of Rebound Migraine Headache
NCT00216736Phase 4Completed
- Sponsor
- Joseph Epstein Centre for Emergency Medicine Research
- Start
- Apr 2005
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in migraine comparing Placebo Comparator with Experimental Dexamethasone (2 arms). Primary endpoints: Proportion of Patients Who Were Discharged Pain Free That Have a Recurrence of Headache Within 48 Hours and Proportion of Patients With Recurrent Headache Within 48 Hours. Started Apr 2005; status: completed.
02
Drugs
dexamethasone
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00216736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216736.